FNV
FRANCO NEVADA CorpMarquee-fund ownership over time
This quarter's activity
New positions opened
Positions exited
None.
Current holders
Sorted by tenure (longest first)| Fund | First disclosed | Held | Entry price | Latest close | Return on entry |
|---|---|---|---|---|---|
| Renaissance Technologies | Q3 2024(8Q snapshot) | 7Q | $120 | $225 | +88% |
| Citadel Advisors re-entered | Q3 2024(8Q snapshot) | 7Q | $116 | $225 | +95% |
| Two Sigma Investments | Q3 2024(8Q snapshot) | 7Q | $116 | $225 | +95% |
| D.E. Shaw | Q3 2024(8Q snapshot) | 7Q | $116 | $225 | +95% |
| Millennium Management | Q3 2024(8Q snapshot) | 7Q | $116 | $225 | +95% |
| Point72 Asset Management re-entered | Q3 2024(8Q snapshot) | 7Q | $116 | $225 | +95% |
| AQR Capital Management | Q2 2025(8Q snapshot) | 4Q | $158 | $225 | +42% |
“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.
Past holders
Funds that exited at some point| Fund | Last entry | Exited | Entry → Exit | Return |
|---|---|---|---|---|
| Bridgewater Associates 3× in & out | Q1 2023 | Q2 2024 | → $125 | -5% |
| Maverick Capital | Q4 2022 | Q3 2023 | → $138 | +1% |
Fundamentals
XBRL · FRANCO NEVADA CorpNot enough XBRL history to plot. FRANCO NEVADA Corphasn't tagged revenue, net income, EPS, or operating cash flow in the SEC us-gaap taxonomy with at least two fiscal-year periods — typical for SPACs / trust vehicles, pre-revenue biotechs, recent IPOs, and foreign filers reporting under IFRS.
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for FRANCO NEVADA Corp — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- 6-KInterim disclosure (foreign)May 13, 2026
- 6-KInterim disclosure (foreign)May 12, 2026
- 6-KInterim disclosure (foreign)May 6, 2026
- 6-KInterim disclosure (foreign)Apr 21, 2026
- 6-KInterim disclosure (foreign)Apr 8, 2026
- 6-KInterim disclosure (foreign)Apr 7, 2026
- 6-KInterim disclosure (foreign)Mar 19, 2026
- 6-KInterim disclosure (foreign)Mar 18, 2026
- 6-KInterim disclosure (foreign)Mar 10, 2026
- 6-KInterim disclosure (foreign)Feb 23, 2026
- 6-KInterim disclosure (foreign)Feb 12, 2026
- 6-KInterim disclosure (foreign)Jan 28, 2026
- 6-KInterim disclosure (foreign)Jan 26, 2026
- 6-KInterim disclosure (foreign)Jan 26, 2026
- 6-KInterim disclosure (foreign)Jan 21, 2026
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Point72 Asset Management | Q2 2026 | open | $225 | $225 | +0% |
| Citadel Advisors | Q1 2026 | open | $249 | $225 | -10% |
| AQR Capital Management | Q2 2025 | open | $158 | $225 | +42% |
| Citadel Advisors | Q3 2024 | Q4 2025 | $116 | $197 | +70% |
| Two Sigma Investments | Q3 2024 | open | $116 | $225 | +95% |
| D.E. Shaw | Q3 2024 | open | $116 | $225 | +95% |
| Millennium Management | Q3 2024 | open | $116 | $225 | +95% |
| Point72 Asset Management | Q3 2024 | Q3 2025 | $116 | $177 | +53% |
| Renaissance Technologies | Q3 2024 | open | $120 | $225 | +88% |
| Bridgewater Associates | Q1 2023 | Q2 2024 | $131 | $125 | -5% |
| Maverick Capital | Q4 2022 | Q3 2023 | $137 | $138 | +1% |
| Bridgewater Associates | Q1 2021 | Q1 2022 | $116 | $138 | +19% |
| Bridgewater Associates | Q3 2013 | Q3 2020 | $37 | $137 | +272% |
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.